US Broker Ratings

ICON plc (ICLR) Stock Analysis: Exploring the 22% Potential Upside for Investors

ICON plc (NASDAQ: ICLR), a pivotal player in the healthcare sector, has carved out a niche within the diagnostics and research industry. Headquartered in Dublin, Ireland,..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Assessing Growth Potential Amidst Challenging Metrics

Bausch + Lomb Corporation (NYSE: BLCO), a prominent name in the healthcare sector, stands out in the medical instruments and supplies industry with its broad international..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Navigating Volatility with Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is drawing significant interest from investors as it carves a niche in the biotechnology sector, focusing on rare neuroendocrine diseases. With..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unveiling a 58.51% Potential Upside with Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has been making waves in the biotechnology sector, primarily focusing on central nervous system (CNS) disorders. With a market capitalization of..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Upside Amid Industry Challenges

Illumina, Inc. (NASDAQ: ILMN) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. Based in the United States, this..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 96% Upside Potential in the Healthcare Sector

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare plans industry, presents an intriguing opportunity for investors, particularly those navigating the evolving dynamics of..

RadNet, Inc. (RDNT) Stock Analysis: Why Analysts Predict a 24% Upside

RadNet, Inc. (NASDAQ: RDNT), a significant player in the healthcare sector, specifically in diagnostics and research, has captured the attention of individual investors and analysts alike...

ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 76% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA) is capturing the attention of investors with a robust potential upside of 76.27%, according to analyst ratings. Operating in the healthcare..

Soleno Therapeutics, Inc. (SLNO) Investor Outlook: Biotech Stock with a 27% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making headlines in the healthcare sector, specifically within the biotechnology industry, as it charts a promising path with its clinical-stage..

Bio-Techne Corp (TECH) Investor Outlook: Analyzing the 29.33% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology industry, is drawing attention from investors with its promising 29.33% potential upside. With a market capitalization..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a Potential 247% Upside with Groundbreaking Vaccine Innovations

Vaxcyte, Inc. (NASDAQ: PCVX) is navigating the biotechnology landscape with a promising portfolio of vaccines designed to combat bacterial infectious diseases. With a market capitalization of..

Verona Pharma (VRNA) Stock Analysis: Strong Buy Ratings and 13.53% Potential Upside

Verona Pharma plc (NASDAQ: VRNA) is making waves in the biotechnology sector, capturing investor attention with its robust portfolio and promising market performance. Headquartered in London..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Innovator with 7.32% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its focus on developing and commercializing therapies for serious and rare diseases. With a market..

Inspire Medical Systems, Inc. (INSP): Growth Potential and Analyst Ratings Signal a Bright Future

Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.74 billion,..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Promising 66.57% Potential Upside with Solid Analyst Support

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a key player in the biotechnology sector, is capturing investor attention with its robust portfolio and promising stock potential. Headquartered in..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 14.91% Upside Potential Boosts Investor Confidence

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 19.76% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector specializing in diagnostics and research, is making waves with its diverse portfolio of solutions..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst Strong ROE and Revenue Growth

DaVita Inc. (NYSE: DVA) stands as a significant player in the healthcare sector, focusing on medical care facilities, specifically kidney dialysis services. With a market cap..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a Potential 18.69% Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector, boasting a market capitalization of $6.96 billion. As a key player in the healthcare..

Viatris Inc. (VTRS) Stock Analysis: A Deep Dive into Its 28% Potential Upside for Investors

Viatris Inc. (NASDAQ: VTRS) finds itself at a critical juncture, poised with a potential upside of 28.24% according to analyst ratings, making it an intriguing prospect..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds